Pharma Journalist
  • facebook
  • twitter
  • google_plus
  • Email
Pharma Journalist

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

CompleWare ventures into agreement with YPrime to offer enhanced eCOA and IRT

Read more

FDA Commissioner Scott Gottlieb,M.D., vows to enhance clarity of Clinical Trial information

Read more

Nils Hauptmann appointed Aerie Pharma’s Director of Regulatory Affairs and Pharmacovigilance

Read more

Ophthotech enlists first patient for Phase 2b Clinical Trial of Zimura to treat STGD1

Read more

FDA issues 510(k) clearance to Centric Medical for Cannulated Screw Internal Fixation System

Read more

New York State Department of Health grants approval to Counsyl for Prelude Prenatal Screen

Read more

VCCN and Alliance Cancer Specialists aspire to offer Oncology Care across Philadelphia

Read more

START collaborates with Sarah Cannon to accelerate Phase I drug development programs

Read more

Ipsen and Exelixis proclaims phase 3 CELESTIAL Trial results in patients with HCC

Read more

AvantGen completes first Cancer therapeutic antibody program for TRL

Read more

Posts pagination

Previous Page 1 of 923 … Page 808 of 923 … Page 923 of 923 Next
  • About
  • Advertise
  • Subscribe
  • Contact
View Desktop Version